Big pharma might cut R&D, delay new drugs if pharmacare means more generics: memo | CBC News
The concerns were
included last year in a briefing document for federal Finance Minister
Bill Morneau that explored the feasibility and costs of a pharmacare
program.
included last year in a briefing document for federal Finance Minister
Bill Morneau that explored the feasibility and costs of a pharmacare
program.
Pharmacare is shaping up as a key campaign issue in the October election, particularly for the Liberals.